-0.77%

Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
Germany
TG
Defence Therapeutics Inc (DTC)
Defence Therapeutics Inc (DTC) News

DTC Defence Therapeutics Inc

0.396

-0.01 (-2.46%)

27 Dec 2024 - Closed

Realtime Data

Share Name	Share Symbol	Market	Type
Defence Therapeutics Inc	TG:DTC	Tradegate	Ordinary Share

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.01	-2.46%	0.396	0.392	0.40	0.426	0.381	0.401	20,585	22:50:01

Domtar announces first quarter 2006 financial results

27/04/2006 2:31pm

PR Newswire (US)

Defence Therapeutics (TG:DTC)
Historical Stock Chart

From Dec 2019 to Dec 2024

Click Here for more Defence Therapeutics Charts.

DTC (TSX,NYSE) MONTREAL, April 27 /PRNewswire-FirstCall/ -- Domtar Inc. announced today a net loss of $24 million ($0.10 per common share) in the first quarter of 2006 compared to net earnings of $10 million ($0.04 per common share) in the first quarter of 2005 and a net loss of $348 million ($1.51 per common share) in the fourth quarter of 2005. > DATASOURCE: DOMTAR INC. CONTACT: Christian Tardif, Manager, Corporate and Financial Communications, (514) 848-5515, ; Investor Relations: Pascal Bosse, Manager, Investor Relations, (514) 848-5938, ; Source: Daniel Buron, Senior Vice-President and Chief Financial Officer, (514) 848-5234, To request a free copy of this organization's annual report, please go to http://www.newswire.ca/ and click on reports@cnw.